Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TOM Weight Loss vs Wisp

TOM Weight Loss
Graded #193

Higher grade

vs+1.8999999999999915
Wisp
Graded #243

Lower grade

The verdict

TOM Weight Loss takes it — 66.3/100 to 64.4/100, but only just.

TOM Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Solo-physician DTC telemedicine clinic in Texas + Utah operated by Dr. Wisp is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTOM Weight Loss +8
58
50
Dose & formulationWisp +14
62
76
Clinical oversightTOM Weight Loss +8
90
82
Labs & monitoringTOM Weight Loss +2
55
53
FulfillmentTOM Weight Loss +7
73
66
Contract termsEven
55
55
TOM Weight Loss · left barWisp · right bar

The numbers

MetricTOM Weight LossWisp
WeighScore66.3/10064.4/100
GradeCC
Scorecard rank#193#243
Semaglutide$199/mo (all doses, compounded)$225/mo (compounded oral)
Tirzepatide$249/mo (all doses, compounded)Not disclosed
Coverage2 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
TOM Weight Loss

Graded #193 · C

Strengths

  • ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
  • Solo-physician model — every patient sees Dr. Le directly
  • Flat-rate pricing — no dose escalation surcharge
  • LegitScript badge displayed
  • No FDA Warning Letters

Where it loses points

  • Limited geographic footprint — Texas and Utah only
  • No named compounding pharmacy partner disclosed
  • Compounded medications are not FDA-approved
  • Cash-pay only, no insurance
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard